期刊文献+

AD7c-NTP在阿尔茨海默病诊断中的研究进展 被引量:7

下载PDF
导出
摘要 阿尔茨海默病(Alzheimer's Disease,AD)是引起痴呆的最主要原因,伴随着人口的老龄化,已成为严重危害老年人健康的一种疾病,引起了全世界的关注。AD的主要的病理学特征是神经元丢失,神经元纤维缠结(neurofibrillary tan- gle,NFT)形成,老年斑(senile plaques,SP)沉积,轴突的异常增生及淀粉样蛋白的蓄积。90%以上AD为散发病例,原因不明,最重要的危险因素是老化。
出处 《中风与神经疾病杂志》 CAS CSCD 北大核心 2007年第3期374-375,共2页 Journal of Apoplexy and Nervous Diseases
  • 相关文献

参考文献1

二级参考文献30

  • 1Hardy J. Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci 1997; 4: 154-9.
  • 2Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002; 297: 353-6.
  • 3Hardy JA, Higgins GA. Alzheimer's disease: the amyloid cascade hypothesis. Science 1992; 256: 184-5.
  • 4Evin G, Weidemann A. Biogenesis and metabolism of Alzheimer's disease AI3 amyloid peptides. Peptides 2002; 23: 1285-97.
  • 5Garcia-Segura LM, Azcoitia I, DonCarlos LL. Neuroprotection by estradiol. Prog Neurobiol 2001; 63: 29-60.
  • 6Owens CT. Estrogen replacement therapy for Alzheimer disease in postmenopausal women. Ann Pharmacother 2002; 36; 1273-6.
  • 7Zheng H, Xu H, Uljon SN, Gross R, Hardy K, Gaynor J, et al. Modulation of A (beta) peptides by estrogen in mouse models. J Neurochem 2002; 80: 191-6.
  • 8Manthey D, Heck S, Engert S, Behl C. Estrogen induces a rapid secretion of amyloid precursor protein via the mitogen-activated protein kinase pathway. Eur J Biochem 2001; 268: 4285-91.
  • 9Singer CA, Figueroa-Masot XA, Batchelor RH, Dorsa DM. The mitogen-activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity in primary cortical neurons. J Neurosci 1999; 19: 2455-63.
  • 10Brewer GJ, Torricelli JR, Evege EK, Price PJ. Optimized survival of hippocampal neurons in B27-supplemented neurobasal, a new serum-free medium combination. J Neurosci Res 1993; 35: 567-76.

共引文献6

同被引文献55

  • 1刘东慧,张新卿,陈彪,汤哲,孙厚亮,王恒,孟超.认知功能筛查量表在MCI和轻度AD患者中的应用[J].脑与神经疾病杂志,2008,16(3):223-226. 被引量:12
  • 2张建平,张新颜.阿尔茨海默病与血浆同型半胱氨酸水平的相关性研究[J].中国基层医药,2006,13(11):1834-1836. 被引量:5
  • 3Monte SM, Ghanbari K, Frey WH, et of the AD7c NTP cDNA expression ease and measurement of a 41 kD pro al. Characterization in Alzheimer's dis- tein in cerebrospinal Clin Invest,1997,100(12):3093 -3104.
  • 4Huisain MM,Garrett RK. Clinical diagnosis and manage- ment of Ahheimer' s disease[J].Neuroimaging Clin N Am,2005,15(6) :767-777.
  • 5Diniz BS, Pinto Junior JA, Forlenza OVDo CSF total tau,phosphorylated tau,and beta amyloid 42 help to pre- dict progression of mild cognitive impairment to Alzhei meres disease? A systematic review and recta-analysis of PsychiaLry, 2008,9 ( 3 ):172-182.
  • 6Munzar M, Levy S, Rush R, et al. Clinical study of a urinary competitve ELISA for neural thread protein in Alzheimer disease [ J]. Neurol Clin Neurophysiol,2002 ,2002 :2-8.
  • 7Levy S, McConville M, Lazaro GA, et al. Competitive ELISA studies of neural thread protein in urine in Alzheimer's disease [ J]. J Clin Lab Anal,2007,21:24-33.
  • 8Zhang J Jr, Shi S Sr. A literature review of AD7C-ntp as a biomarker for Alzheimer's disease [ J ]. Ann Indian Acad Neurol, 2013,16:307-309.
  • 9Zhang J, Zhang CH, Li R J, et al. Accuracy of Urinary AD7 C-NTP for Diagnosing Alzheimer's Disease: A Systematic Review and Meta-Analysis [ J ]. J Alzheimers Dis ,2014,40 : 153-159.
  • 10Petersen RC, Doody R, Kurz A, et al. Current concepts in mild cognitive imoairment [J]. Arch Neurol.2001.58 ,1985-1992.

引证文献7

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部